Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Recs

0
Player Avatar UBishops09 (63.25) Submitted: 8/6/2009 7:02:36 PM : Outperform Start Price: $20.05 CBST Score: +67.36

Inexpensive and managements expansion plans seem bullish.

Featured Broker Partners


Advertisement